There is increasing recognition in the neurological and psychiatric literature of patients with
so-called isolated psychotic presentations (ie, with no, or minimal, neurological features) …

Seizures are a well‐recognized and often prominent manifestation of autoimmune
encephalitic syndromes. Progress in detection of pathogenic neural autoantibodies has led …

Importance Overall, immunotherapy has been shown to improve outcomes and reduce
relapses in individuals withN-methyl-d-aspartate receptor (NMDAR) antibody encephalitis …

Objective: This nationwide study gives a detailed description of the clinical features and long-
term outcome of anti–leucine-rich glioma-inactivated 1 (LGI1) encephalitis. Methods: We …

Objective To create an international consensus treatment recommendation for pediatric
NMDA receptor antibody encephalitis (NMDARE). Methods After selection of a panel of 27 …

Summary Background Anti-NMDA receptor (NMDAR) encephalitis is an autoimmune
disorder in which the use of immunotherapy and the long-term outcome have not been …

Over the past 10 years, the continual discovery of novel forms of encephalitis associated
with antibodies to cell‐surface or synaptic proteins has changed the paradigms for …

Autoimmune encephalitis is a relatively new category of immune-mediated disease
involving the central nervous system that demonstrates a widely variable spectrum of clinical …

Abstract Background. In 2007, the California Encephalitis Project (CEP), which was
established to study the epidemiology of encephalitis, began identifying cases of anti-N …

Autoimmune encephalitis is one of the most rapidly growing research topics in neurology.
Along with discoveries of novel antibodies associated with the disease, clinical experience …